本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rapid Micro Biosystems, Inc.

3.08
+0.14004.76%
盘后3.080.00000.00%19:10 EDT
成交量:13.48万
成交额:39.55万
市值:1.36亿
市盈率:-3.07
高:3.08
开:2.88
低:2.78
收:2.94
52周最高:4.50
52周最低:0.8300
股本:4,421.03万
流通股本:1,933.78万
量比:1.60
换手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-1.0020
每股收益(LYR):-1.0760
净资产收益率:-59.15%
总资产收益率:-29.89%
市净率:2.50
市盈率(LYR):-2.86

数据加载中...

2023/05/15

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/05/12

SEC问询函

Form CORRESP - Correspondence
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/08

重要事件披露

8-K - Current report
2023/05/05

重要事件披露

8-K - Current report
2023/05/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/03

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/11

重要事件披露

8-K - Current report
2022/12/01

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/12

重要事件披露

8-K - Current report
2022/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]